Master Class III Antiarrhythmics (K+ Channel Blockers) with Picmonic for Medicine

Because of its side effect profile, these drugs are prescribed after other anti-arrhythmics fail, and are indicated to treat arrhythmias and prevent re-entrant arrhythmias.

These drugs increase AP (action potential) duration, ERP (effective refractory period), and QT interval. They do not slow conduciton velocity, but rather, they prolong repolarization in atrio-ventricular myocytes.

Amiodarone increases refractoriness and has a long half-life. It is indicated for refractory life-threatening ventricular arrhythmias, and is the first line treatment for patients not responding to CPR. Amiodarone is unique, as it has class I, II, III, IV antiarrhythmic effects because it alters the lipid membrane.

When using amiodarone, doctors must check pulmonary, liver and thyroid function tests because of the documented toxicities of the drug. It is known to cause pulmonary fibrosis, hepatotoxicity and hypo/hyperthyroidism.

Amiodarone is referred to as a "dirty drug" because it can bind to several different targets or receptors and thus have a wide range of effects. Side effects include cardiovascular effects (CHF, heart block, bradycardia), pulmonary fibrosis, hepatotoxicity, thyroid issues, corneal deposits, skin discoloration, neurological effects, and constipation.

Ibutilide is indicated for quick conversion of atrial flutter or atrial fibrillation to a normal sinus rhythm. It is administered only through IV infusion and works by prolonging action potential duration. A side effect is torsades de pointes.

Dofetilide is indicated for converting and maintaining normal sinus rhythm in the case of atrial flutter or atrial fibrillation.

Another class III antiarrhythmic is the non-selective competitive β-adrenergic receptor blocker called Sotalol. It has significant side effects, including dyspnea, dizziness and torsades de pointes.

Multiple class effects of this drug can cause excessive β-block on the heart. Sotalol is also a nonselective β-blocker.